Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noninvasively Predicting Isocitrate Dehydrogenase Gene Status in Glioma by Amide Proton Transfer Imaging

NCT03102112 is registered in ClinicalTrials.gov with Tang-Du Hospital as lead sponsor.

NCT NCT03102112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03102112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noninvasively Predicting Isocitrate Dehydrogenase Gene Status in Glioma by Amide Proton Transfer Imaging
Lead sponsor
Tang-Du Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2017
Completion date
March 3, 2018
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma of brain